QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

AbCellera Biologics (ABCL) Insider Trading & Ownership

$4.95
+0.08 (+1.64%)
(As of 02/26/2024 ET)

AbCellera Biologics (NASDAQ:ABCL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
32.45%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$1.10 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get ABCL Insider Trade Alerts

Want to know when executives and insiders are buying or selling AbCellera Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ABCL Insider Buying and Selling by Quarter


AbCellera Biologics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2023Andrew BoothCFOBuy14,500$6.85$99,325.00  
5/26/2023Holdings Ltd. ThermopylaeMajor ShareholderBuy153,000$6.52$997,560.00  
(Data available from 1/1/2013 forward)












ABCL Insider Trading Activity - Frequently Asked Questions

Who is on AbCellera Biologics's Insider Roster?

The list of insiders at AbCellera Biologics includes Andrew Booth, Andrew Lo, Carl L G Hansen, Holdings Ltd. Thermopylae, John Hamer, John S Montalbano, Michael R Hayden, and Veronique Lecault. Learn more on insiders at ABCL.

What percentage of AbCellera Biologics stock is owned by insiders?

32.45% of AbCellera Biologics stock is owned by insiders. Learn more on ABCL's insider holdings.

Which AbCellera Biologics insiders have been buying company stock?

The following insiders have purchased ABCL shares in the last 24 months: Andrew Booth ($591,475.00), Holdings Ltd. Thermopylae ($14,102,425.03), John S Montalbano ($266,400.00), and Veronique Lecault ($3,266,632.74).

How much insider buying is happening at AbCellera Biologics?

Insiders have purchased a total of 2,526,319 ABCL shares in the last 24 months for a total of $18,226,932.77 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ABCL) was last updated on 2/26/2024 by MarketBeat.com Staff